| Barchart Demo Center |
$47.30
+0.37 (+0.79%)
as of May 17, 2024
as of May 17, 2024
| Last | 47.30 |
|---|---|
| Change | +0.37 (+0.79%) |
| Open | 46.78 |
| Prev. Close | 46.93 |
| Today's Range |
45.76
47.69
|
| 52wk Range |
13.82
47.88
|
| Volume | 1,123,100 |
| Avg Volume | 1,707,440 |
| Sector | SIC-3841 Surgical & Medical Instruments & Apparatus |
Perfomance Comparison
| Name | Today | 3-Month | 1-Year |
|---|---|---|---|
| TNDM |
 +0.79% |
 +59.42% |
+55.54% |
| DJIA |
+0.34% |
+3.13% |
+19.70% |
| S&P 500 |
+0.12% |
+2.83% |
+27.52% |
Key Statistics
| Annual EPS | -2.17 |
|---|---|
| Dividend Yield | 0.00% |
| P/E Ratio | N/A |
| Market Capitalization, $K | 2,846,460 |
| Weighted Alpha | +85.57 |
| Standard Deviation | +0.15 |
| Profit Margin | -18.37% |
| Beta | 1.10 |
Growth Rates
| YTD | +59.91% | |||
| 1-Year | +66.89% | |||
| 3-Year | -45.26% | |||
| 5-Year | -28.20% | |||
| 10-Year | -71.10% |
Opinion
| Sell | Hold | Buy |
Recent Headlines
Tandem Diabetes Care Announces First Quarter 2024
Business Wire - Thu May 02, 03:05PM CDT
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2024 and increased sales guidance for the year ending Decem(full story)
TNDM: 47.30 (+0.37)
Tandem Diabetes Care Announces Upcoming Conference
Business Wire - Mon Apr 29, 03:05PM CDT
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:(full story)
TNDM: 47.30 (+0.37)
Tandem Diabetes Care to Announce First Quarter 2024
Business Wire - Tue Apr 09, 03:05PM CDT
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will ho(full story)
TNDM: 47.30 (+0.37)
Tandem Diabetes Care Prices Upsized Private Placement
Business Wire - Tue Mar 05, 11:46PM CST
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $275.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 (the “(full story)
TNDM: 47.30 (+0.37)
Tandem Diabetes Care Announces Proposed Private
Business Wire - Mon Mar 04, 03:05PM CST
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today that it intends to offer, subject to market conditions and other factors, $250.0 million aggregate principal amo(full story)
TNDM: 47.30 (+0.37)